首页> Cancer> Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.

Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.

导出 OA

翻译打印收藏纠错

第一作者： Charles A,Schiffer

第一单位： Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

作者： Charles A,Schiffer ^[1] ; Jorge E,Cortes ^[2] ; Andreas,Hochhaus ^[3] ; Giuseppe,Saglio ^[4] ; Philipp,le Coutre ^[5] ; Kimmo,Porkka ^[6] ; Satu,Mustjoki ^[6] ; Hesham,Mohamed ^[7] ; Neil P,Shah ^[8]

作者单位： Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. ^[1] The University of Texas M.D. Anderson Cancer Center, Houston, Texas. ^[2] Jena University Hospital, Jena, Germany. ^[3] San Luigi Gonaga Hospital, University of Turin, Orbassano-Turin, Italy. ^[4] Charite-Campus Virchow Clinic, Berlin Medical University, Berlin, Germany. ^[5] Department of Hematology and Hematology Research Unit, Helsinki University Central Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland. ^[6] Bristol-Myers Squibb, Princeton, New Jersey. ^[7] University of California, San Francisco School of Medicine, San Francisco, California. ^[8]

关键词 T-lymphocytes chronic myeloid dasatinib killer cells leukemia lymphocytosis natural